Showing results (111-120 of 166) with videos related to
Sort By:
Pageof 17
Cellular Oncology (Dordrecht, Netherlands)|December 28, 2021
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doublingSara Vanessa Bernhard, Katarzyna Seget-Trzensiok, Christian Kuffer, et al.Journal of the International AIDS Society|November 15, 2014
Universal Tre (uTre) recombinase specifically targets the majority of HIV-1 isolatesJanet Karpinski, Jan Chemnitz, Ilona Hauber, et al.Nature Biotechnology|January 31, 2024
Activation of recombinases at specific DNA loci by zinc-finger domain insertionsLiliya Mukhametzyanova, Lukas Theo Schmitt, Julia Torres-Rivera, et al.Cancers|March 25, 2022
Updated Prognostic Factors in Localized NSCLCSimon Garinet, Pascal Wang, Audrey Mansuet-Lupo, et al.Cancers|November 14, 2023
Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung CancerLahcene Belaidi, Pascal Wang, Kevin Quintin, et al.Cell|October 27, 2015
A human interactome in three quantitative dimensions organized by stoichiometries and abundancesMarco Y Hein, Nina C Hubner, Ina Poser, et al.Cancers|August 12, 2023
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian CancerDaniel Martin Klotz, Franziska Maria Schwarz, Anna Dubrovska, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2023
Precise excision of HTLV-1 provirus with a designer-recombinaseTeresa Rojo-Romanos, Janet Karpinski, Sebastian Millen, et al.EMBO Reports|May 14, 2017
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activatorArne Jahn, Grishma Rane, Maciej Paszkowski-Rogacz, et al.Frontiers in Oncology|August 12, 2022
Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case reportPascal Wang, Emmanuelle Fabre, Antoine Martin, et al.Pageof 17